CD8A and rectal cancer: Moreover, in patients with colon or rectal cancer, the CD8+ index (P=0.015 and P=0.006, respectively) as well as the CD8+/ buds index (P=0.002 and P=0.016, respectively) maintained a significant independent prognostic effect after adjusting for pT stage, pN stage and vascular invasion.